Safety and Feasibility of Radiation Therapy Combined with CDK 4/6 Inhibitors in the Management of Advanced Breast Cancer

Safety and Feasibility of Radiation Therapy Combined with CDK 4/6 Inhibitors in the Management of Advanced Breast Cancer

The addition of CDK4/6 inhibitors to endocrine therapy in advanced hormone receptor-positive HER2-negative breast cancer has led to practice-changing improvements in overall survival. However, data concerning the safety of CDK4/6i combination with radiotherapy (RT) are conflicting. A retrospective e...

Full description

Bibliographic Details
Main Authors: Marcin Kubeczko, Dorota Gabryś, Marzena Gawkowska, Anna Polakiewicz-Gilowska, Alexander J. Cortez, Aleksandra Krzywon, Grzegorz Woźniak, Tomasz Latusek, Aleksandra Leśniak, Katarzyna Świderska, Marta Mianowska-Malec, Barbara Łanoszka, Konstanty Chomik, Mateusz Gajek, Anna Michalik, Elżbieta Nowicka, Rafał Tarnawski, Tomasz Rutkowski, Michał Jarząb
Format: Article
Language:English
Published: MDPI AG 2023-01-01
Series:Cancers
Subjects:
abemaciclib
palbociclib
ribociclib
CDK 4/6 inhibitors
radiotherapy
advanced breast cancer
Online Access:https://www.mdpi.com/2072-6694/15/3/690

Internet

https://www.mdpi.com/2072-6694/15/3/690

Similar Items